Back

Dr.Agarwal's Health Care Ltd.

IPO Details · GMP · Subscription · Financials

✅ Listed NSE & BSE Mainboard Live Chart
Issue Price
₹402
Per Share
GMP
NIL
Grey Market
Est. Listing
₹402
Expected Price
Min. Application
₹28,140
2 lots × 35 shares
IPO Issue Details
Issue Price / Price Band₹402 per share (Fixed Price)
Face Value₹1 Per Share
Lot Size35 Shares per Lot
Total Issue Size7,53,04,970 shares (aggregating up to ₹3,027.26 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenWed, 29 Jan 2025
Subscription CloseFri, 31 Jan 2025
Anchor AllotmentTue, 28 Jan 2025
Basis of AllotmentMon, 03 Feb 2025
Initiation of RefundsTue, 04 Feb 2025
Credit of Shares to DematTue, 04 Feb 2025
Listing DateTue, 04 Feb 2025
UPI Mandate Deadline2025-01-31
Application & Investment Details
Retail — Min (1 Lots)14,070 — 35 shares
Retail — Max (13 Lots)₹182,910 (13 Lots)
HNI — Min (72 Lots)10,13,040 — 2520 shares
EPS (Pre-IPO)₹3.08
EPS (Post-IPO)₹2.51
P/E Ratio (Pre-IPO)130.44x
P/E Ratio (Post-IPO)160.48x
Pre-IPO Promoter Holding30,84,17,160 shares
Post-IPO Promoter Holding31,58,79,846 shares
Fresh Issue Shares74,62,686 shares (aggregating up to ₹300.00 Cr)
Offer for Sale Shares6,78,42,284 shares of ₹1 (aggregating up to ₹2,727.26 Cr)
About Dr.Agarwal's Health Care Ltd.

Incorporated in 2010, Dr. Agarwal's Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.As of September 30, 2024, there were 737 doctors providing care to patients across the company's facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries.The Services provided by the company are:-Cataract surgeries Offer cataract surgical treatments at its Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments;Refractive surgeries: Refractive surgeries are procedures that correct eye refractive errors, helping individuals reduce or eliminate their need for glasses and contact lenses. The main types include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).Other surgeries: Offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.As of September 30, 2024, the company's Indian network has 28 hubs (Tertiary Facilities, including three COEs) and 165 spokes (53 Primary and 112 Secondary Facilities).As of September 30, 2024, the company has a presence in India across 117 metro and non-metro cities spanning 14 states and four union territories through 193 Facilities.Competitive StrengthLargest eye care services provider in India with a trusted brandEnd-to-end, comprehensive eye care services offeringScalable, asset-light, hub-and-spoke operating modelProven clinical excellence is driven by a strong clinical board and a history of surgical innovations. Doctor-promoters leading a team of qualified medical professionals and supported by experienced managementProven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability

Objects of the Issue

Dr.Agarwal's Health Care Ltd. proposes to utilise the net proceeds from the Issue for the following objects:

1
Repayment/prepayment, in part or full, of certain of the borrowings
2
General corporate purposes and unidentified inorganic acquisition.
Shareholding & Lock-in
Pre-IPO Promoter Holding 30,84,17,160 shares
Post-IPO Promoter Holding 31,58,79,846 shares
Lock-in Period (30%)March 2, 2025
Lock-in Period (50%)May 1, 2025
Check AllotmentCheck Status →
Dr.Agarwal's Health Care Ltd. — Live Price LIVE
₹402.00
INR · BSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Dr.Agarwal's Health Care Ltd. is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹402.00 Live Price
Quick Facts
GMP Signal ⚪ No GMP
StatusListed
Issue Price₹402
GMPNIL
Est. Listing₹402
Lot Size35 shares
Min Amount₹28,140
Listing Date04 Feb 2025
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹402
Listing Date04 Feb 2025
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
TOTAL 75,304,970 100.00% ₹3,027.26 Cr
* Based on ₹402.00 (upper price band)
Lot Size & Investment Details
Lot Size
35
Shares
Issue Price
₹402.00
Per Share
Min Investment
₹14,070
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 35 ₹14,070
Retail (Max) 13 455 ₹182,910
sNII (Min) 15 525 ₹211,050
bNII (Min) 72 2,520 ₹1,013,040
Company Financials — Restated Consolidated (Amount in ₹ Crore)
Particulars30 Sep 202431 Mar 202431 Mar 2023
Revenue from Operations 837.94 1376.45 1031.49
EBITDA N/A N/A N/A
Profit After Tax (PAT) 39.56 95.05 103.23
Net Worth 1502.67 1337.68 627.83
Total Assets 3393.41 2752.82 1825.17
Reserves & Surplus 1509.11 1365.86 652.63
Total Borrowings 373.68 387.79 356.18
Key Ratios & Valuation
Issue Price ₹402
Face Value ₹1 Per Share
P/BV 7.96
RoE 9.33%
RoCE 14.61%
RoNW 6.21
PAT Margin (%) 6.90%
EBITDA Margin (%) N/A
Debt / Equity N/A
Company Details
Company
Dr.Agarwal's Health Care Ltd.
Exchange
NSE & BSE
IPO Type
Mainboard IPO
Issue Type
Bookbuilding IPO
Face Value
₹1 Per Share
Script Code
N/A
Address
1 st Floor, Buhari Towers No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006 Chennai, Tamil Nadu
Book Running Lead Managers
Kotak Mahindra Capital Co.Ltd
Book Running Lead Manager (BRLM)
Morgan Stanley India Co.Pvt.Ltd
Book Running Lead Manager (BRLM)
Jefferies India Pvt.Ltd
Book Running Lead Manager (BRLM)
Motilal Oswal Investment Advisors Ltd
Book Running Lead Manager (BRLM)